Articles & Video
Future Trends in Proteins To Fight COVID-19
The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
BioProcess International 2020 Post-Event Report
Explore the highlights of the BioProcess International 2020 virtual conference in the post-event round-up.
Novel Antibody Therapeutic Modalities - Antibody Therapeutics eBook Series
We take an in-depth look at the novel antibody therapeutic modalities being developed and how they are tackling new non-cancer targets in this Antibody Therapeutics eBook.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
Post-Event Report: Antibody Engineering and Therapeutics Europe 2020
Explore the highlights of Antibody Engineering & Therapeutics Europe Virtual 2020 in this post-event report.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Diversity and Inclusion in Biotech
The life science industry has a challenge to become more equal, diverse and inclusive. Join us at Diversity and Inclusion in Biotech, September 22nd and find out how TOGETHER we can make a difference.
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
42% of pharma industry believe cell and gene therapies to be most promising therapeutics
According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
Podcast: How to Create the Ultimate Bispecific
What goes into making the perfect bispecific? In our first Life Sciences podcast, we find out the best steps from Volker Schellenberger at Amunix.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Strategies to Innovate the Production of Next Generation Bioconjugates
From developing ADCs to tumor-targeting, this whitepaper reviews the latest common challenges and novel strategies for producing bioconjugates.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
The role of COVID-19 antibody testing for employers
How can widespread COVID-19 antibody testing help reopen offices and how close are we to achieving it?
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?